The American Society of Hematology (ASH) announced the names of 11 outstanding fellows selected to receive the 2017 ASH Research Training Award for Fellows, a year-long program that aims to encourage careers in academic hematology by providing protected research time during training. Each awardee will receive $70,000 to support a hematology research project throughout the program’s duration, from July 1, 2017, to June 30, 2018.
Award Recipients and Research Topics
The 2017 ASH Research Training Award for Fellows recipients and their research topics follow:
- Akshay Sharma, MBBS, University of Tennessee: Enhancer dissection to understand fetal hemoglobin regulation
- Allison Remiker, MD, Cincinnati Children’s Hospital Medical Center: Mechanisms linking fibrin(ogen) structure/function to tumor metastasis
- Ami Patel, MD, University of Utah: Bone marrow stroma-based mechanisms of resistance in FLT3-ITD–positive acute myeloid leukemia
- Hojun Li, MD, PhD, Boston Children’s Hospital: Deciding cell fate in hematopoiesis: Asymmetric cell division in erythropoiesis as a model
- Kandace Gollomp, MD, University of Pennsylvania: A proposed role for neutrophils and NETs in the pathogenesis of heparin-induced thrombocytopenia
- Kelly Bolton, MD, PhD, Memorial Sloan Kettering Cancer Center/New York Presbyterian: The impact of oncologic therapy on clonal hematopoiesis and secondary leukemia
- Pamela Sung, MD, PhD, University of Pennsylvania: Understanding mechanisms of primary resistance to targeted therapy in FLT3-mutated acute myeloid leukemia
- Ryan Woods, MD, Wake Forest University School of Medicine: Development of a nanobody against wild-type and mutant calreticulin
- Sarah Buckley, MD, Fred Hutchinson Cancer Research Center: Disease-specific measurement of quality of life and adverse events in patients with acute myeloid leukemia
- Seongseok Yun, MD, PhD, University of South Florida, Morsani College of Medicine: The role of c-MYC and TFEB in the acute myeloid leukemia leukemogenesis
- Tian Yi Zhang, MD, PhD, Stanford University: Dissecting the mechanism of bone marrow failure in acute myeloid leukemia ■
